Amniotic fluid embolism (AFE) is a pregnancy complication known to be extremely hard to diagnose, since it manifests itself abruptly and with no warning signs, presenting an incidence rate of about 1 in 40000 deliveries, and maternal morbidity and mortality ranging from 20% to 60%. Although almost a century has gone by since it was first identified (1926) and despite medical research having been conducted on such a syndrome, diagnostic procedures and treatment methods have not yet been clarified enough. Specific biochemical markers have been produced in research laboratories, but their clinical value results to be limited, given how rapid the pathological process moves forward. At the time being, no diagnosis is feasible which may effectively prevent the disease from occurring. Certainly, a multidisciplinary approach might contribute to saving the lives of mother and infant, as well as ensuring better life standards. The paper's authors aim to highlight the medico-legal issues, in light of several rulings from the Italian Constitutional Court as well as lower courts. The authors also advocate for the creation of a nation-wide registry meant to collect all signaled AFE instances so that research on this as yet devastating syndrome can be conducted based on hard data.

Assessing malpractice lawsuits for death or injuries due to amniotic fluid embolism / Zaami, Simona; Marinelli, Enrico; MONTANARI VERGALLO, Gianluca. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - STAMPA. - 168:3(2017), pp. 220-224. [10.7417/CT.2017.2010]

Assessing malpractice lawsuits for death or injuries due to amniotic fluid embolism

ZAAMI, Simona;MARINELLI, Enrico;MONTANARI VERGALLO, GIANLUCA
2017

Abstract

Amniotic fluid embolism (AFE) is a pregnancy complication known to be extremely hard to diagnose, since it manifests itself abruptly and with no warning signs, presenting an incidence rate of about 1 in 40000 deliveries, and maternal morbidity and mortality ranging from 20% to 60%. Although almost a century has gone by since it was first identified (1926) and despite medical research having been conducted on such a syndrome, diagnostic procedures and treatment methods have not yet been clarified enough. Specific biochemical markers have been produced in research laboratories, but their clinical value results to be limited, given how rapid the pathological process moves forward. At the time being, no diagnosis is feasible which may effectively prevent the disease from occurring. Certainly, a multidisciplinary approach might contribute to saving the lives of mother and infant, as well as ensuring better life standards. The paper's authors aim to highlight the medico-legal issues, in light of several rulings from the Italian Constitutional Court as well as lower courts. The authors also advocate for the creation of a nation-wide registry meant to collect all signaled AFE instances so that research on this as yet devastating syndrome can be conducted based on hard data.
amniotic fluid embolism; medical liability; national register; pregnancy complication; risk factors
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Assessing malpractice lawsuits for death or injuries due to amniotic fluid embolism / Zaami, Simona; Marinelli, Enrico; MONTANARI VERGALLO, Gianluca. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - STAMPA. - 168:3(2017), pp. 220-224. [10.7417/CT.2017.2010]
File allegati a questo prodotto
File Dimensione Formato  
Zaami_Assessing malpractice_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 133 kB
Formato Adobe PDF
133 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/993495
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact